You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

Metyrapone - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard


What are the generic drug sources for metyrapone and what is the scope of freedom to operate?

Metyrapone is the generic ingredient in one branded drug marketed by Hra Pharma and is included in one NDA. Additional information is available in the individual branded drug profile pages.

There is one drug master file entry for metyrapone. One supplier is listed for this compound.

Summary for metyrapone
US Patents:0
Tradenames:1
Applicants:1
NDAs:1
Drug Master File Entries: 1
Finished Product Suppliers / Packagers: 1
Raw Ingredient (Bulk) Api Vendors: 109
Clinical Trials: 21
Patent Applications: 2,413
What excipients (inactive ingredients) are in metyrapone?metyrapone excipients list
DailyMed Link:metyrapone at DailyMed
Recent Clinical Trials for metyrapone

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Mayo ClinicPhase 2
Biostat Sp. z o.o.Phase 2
Maria Sklodowska-Curie National Research Institute of OncologyPhase 2

See all metyrapone clinical trials

Pharmacology for metyrapone
Medical Subject Heading (MeSH) Categories for metyrapone
Anatomical Therapeutic Chemical (ATC) Classes for metyrapone

US Patents and Regulatory Information for metyrapone

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Hra Pharma METOPIRONE metyrapone TABLET;ORAL 012911-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Hra Pharma METOPIRONE metyrapone CAPSULE;ORAL 012911-002 Aug 9, 1996 RX Yes Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.